PLA2G7 and peripheral arterial disease: Hence, it is likely that individuals that later develop symptomatic PAD as opposed to asymptomatic PAD may have been exposed to larger amounts of pathophysiological stimulators such as Lp-PLA2, promoting development of PAD.